Skip to Main Content

Author Details

Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
2005
114
34
PMIDPaper TitleJournal TitlePublished Year
36454217A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms.G3 (Bethesda)2023
37905142Interactions between ploidy and resource availability shape clonal interference at initiation and recurrence of glioblastoma.bioRxiv2023
37802604Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.J Immunother Cancer2023
37978271Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy.Sci Rep2023
37095442Fast all versus all genotype comparison using DNA/RNA sequencing data: method and workflow.BMC Bioinformatics2023
37185232Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma.J Immunother Cancer2023
36454217A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms.G3 (Bethesda)2023
37802604Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.J Immunother Cancer2023
37905142Interactions between ploidy and resource availability shape clonal interference at initiation and recurrence of glioblastoma.bioRxiv2023
37978271Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy.Sci Rep2023
37185232Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma.J Immunother Cancer2023
37095442Fast all versus all genotype comparison using DNA/RNA sequencing data: method and workflow.BMC Bioinformatics2023
33994165Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma.Eur Urol Focus2022
36092893Evolutionary selection identifies critical immune-relevant genes in lung cancer subtypes.Front Genet2022
35500227Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma.Blood Adv2022
36215121Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.Clin Cancer Res2022
36139469Drepmel-A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment.Cells2022
35987136Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity.Mol Immunol2022
35718636Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma.Eur Urol2022
36612014Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes.Cancers (Basel)2022
33994165Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma.Eur Urol Focus2022
35289298The Radiosensitivity Index Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated With Susceptibility to Radiation Therapy.Int J Radiat Oncol Biol Phys2022
35247927Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy.Clin Cancer Res2022
35032707Mitochondrial DNA sequence variation and risk of glioma.Mitochondrion2022
35031572Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma.Cancer Res2022
34965383Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.Am J Hum Genet2022
35500227Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma.Blood Adv2022
35718636Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma.Eur Urol2022
36612014Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes.Cancers (Basel)2022
36215121Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.Clin Cancer Res2022
36139469Drepmel-A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment.Cells2022
35987136Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity.Mol Immunol2022
36092893Evolutionary selection identifies critical immune-relevant genes in lung cancer subtypes.Front Genet2022
35289298The Radiosensitivity Index Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated With Susceptibility to Radiation Therapy.Int J Radiat Oncol Biol Phys2022
35247927Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy.Clin Cancer Res2022
35032707Mitochondrial DNA sequence variation and risk of glioma.Mitochondrion2022
35031572Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma.Cancer Res2022
34965383Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.Am J Hum Genet2022
32926368Managing a Large-Scale Multiomics Project: A Team Science Case Study in Proteogenomics.Methods Mol Biol2021
31901438Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.Eur Urol Focus2021
33671939The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer.Cancers (Basel)2021
33989014Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt Experience.JCO Clin Cancer Inform2021
34095711Integrating Somatic and Germline Next-Generation Sequencing Into Routine Clinical Oncology Practice.JCO Precis Oncol2021
34250383Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in <i>KRAS</i> Wild-Type Pancreatic Cancer.JCO Precis Oncol2021
33978681A Mutational Survey of Acral Nevi.JAMA Dermatol2021
33037322Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas.Lab Invest2021
32926368Managing a Large-Scale Multiomics Project: A Team Science Case Study in Proteogenomics.Methods Mol Biol2021
33346915Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response.Clin Exp Immunol2021
34793338Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma.JCI Insight2021
34619428Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability.Neoplasia2021
  • 1 - 50 of 228

Recommended Authors

Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 4
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 1
The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 2
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 11
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 29
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 7
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 3
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 25
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 10
University of Augsburg
Career Start Year 2004
Number of shared co-authors 1
Washington University
Career Start Year 2003
Number of shared co-authors 6
Washington University
Career Start Year 2003
Number of shared co-authors 10
University of California
Career Start Year 2003
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 3
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 6
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 7
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 7
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 3
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 7
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 19
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 10
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 20
Wellcome Sanger Institute
Career Start Year 1996
Number of shared co-authors 14
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 32
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 25
The Ohio State University
Career Start Year 1988
Number of shared co-authors 24
Broad Institute
Career Start Year 1983
Number of shared co-authors 19

Collaborators

National Human Genome Research Institute, National Institutes of Health
Co-authored papers 16
Co-authored papers 12
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 11
Moffitt Cancer Center
Co-authored papers 8
H. Lee Moffitt Cancer Center & Research Institute
Co-authored papers 8
University of Colorado School of Medicine
Co-authored papers 7
Sanford School of Medicine, University of South Dakota
Co-authored papers 7
Center for Precision Health Research, National Human Genome Research Institute
Co-authored papers 7
Weizmann Institute of Science
Co-authored papers 7
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 7
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 6
National Human Genome Research Institute, US National Institutes of Health
Co-authored papers 6
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 6
Cornell University
Co-authored papers 5
Mayo Clinic College of Medicine
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
National Cancer Institute
Co-authored papers 4
Cedars-Sinai Medical Center
Co-authored papers 4
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 4
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 4
Rollins School of Public Health, Emory University
Co-authored papers 3
The Prostate Cancer Clinical Trials Consortium
Co-authored papers 3
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 3
Co-authored papers 3
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 3
University of Colorado Anschutz Medical Campus
Co-authored papers 3